ACI-12589
- Generic Name
- ACI-12589
Study to Evaluate a Potential PET Radioligand for Imaging Alpha-synuclein Deposits in the Brain
Early Phase 1
Completed
- Conditions
- Alpha-SynucleinopathyParkinson's DiseaseDementia With Lewy BodiesMultisystem Atrophy
- Interventions
- First Posted Date
- 2024-06-06
- Last Posted Date
- 2025-02-19
- Lead Sponsor
- Invicro
- Target Recruit Count
- 12
- Registration Number
- NCT06445465
- Locations
- 🇺🇸
Invicro, New Haven, Connecticut, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath